Synapse - Tasneem Balasinorwala

Search Within

Tasneem Balasinorwala

Results (1)

The majority of patients with relapsing light chain (AL) amyloidosis are not eligible for enrollment onto clinical trials: Using screen failures to define major unmet medical needs

Meeting Abstract

Landau, H.; Comenzo, R. L.; Balasinorwala, T.; Warner, M.; Landgren, O.; Giralt, S. A.; Hassoun, H.
Blood (2015)

Fulltext@MSK | Save